Literature DB >> 507290

Prevention of distal embolism during arterial reconstruction.

D S Starr, G M Lawrie, G C Morris.   

Abstract

Distal embolization of fragmented laminated thrombus and atheroma producing peripheral ischemia or gangrene is an underemphasized complication of arterial reconstruction. A set of techniques has been developed to minimize this important complication. To assess their effectiveness, the incidence of distal embolism in patients undergoing resection of abdominal aortic aneurysm with and without the use of these techniques was studied. In the 434 patients who underwent elective resection of abdominal aneurysm, measures to prevent distal embolism were used in all cases. The incidence of distal embolism was only 0.23 per cent (1 of 434), in contrast to reported incidences of up to 11 per cent. In the 21 patients who underwent emergency resection of ruptured aneurysm, these techniques were not used due to the need for early proximal control for resuscitation; distal embolism of atheromatous material occurred in 2 cases, an incidence of 9 per cent. The application of these techniques to other peripheral vascular procedures has resulted in similar low rates of postoperative distal ischemia.

Entities:  

Mesh:

Year:  1979        PMID: 507290     DOI: 10.1016/0002-9610(79)90293-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  [Sexual function after vascular surgical interventions in the aortoiliac area--causes and the avoidance of impotence].

Authors:  O Thetter; A von Hochstetter; R J van Dongen
Journal:  Langenbecks Arch Chir       Date:  1984

2.  Progress in the treatment of ruptured abdominal aortic aneurysm.

Authors:  G M Lawrie; E S Crawford; G C Morris; J F Howell
Journal:  World J Surg       Date:  1980-11       Impact factor: 3.352

3.  Local complications after arterial bypass grafting.

Authors:  W B Campbell; L J Tambeur; V R Geens
Journal:  Ann R Coll Surg Engl       Date:  1994-03       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.